Home
Duchenne
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
Search
About Us
Contact
Privacy Policy
type here...
Search
Instagram
Facebook
Twitter
Bluesky
Home
Duchenne
Duchenne MD
What is Duchenne?
Genetic Causes
Creatine Kinase (CK)
Genetic Testing
Prenatal Testing
Becker MD
DMD vs BMD
NSAA Assessment
Genetic
Genetic Counseling
Exon Check Tool
Dystrophin Gene
Genetic Variants
Exon Deletion
Duchenne Carriers
Nucleotides in DMD
Isoforms in DMD
Care Guidelines
Newly Diagnosed
Neuromuscular Team
Respiratory Devices
BiPAP Machine
Ankle Foot Orthosis
Rhabdomyolysis
Power Wheelchair
Traveling with DMD
Health Guidelines
Psychological Support in DMD
Nutrition in DMD
Nutraceuticals
Respiratory Health
Dental Health
Surgery & Anesthesia
Swallowing Difficulty
Steroids (Cortisone)
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
WhatsAPP
Facebook
Instagram
X
Youtube
Latest Posts
Research
DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD
Care Guidelines
What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?
Care Guidelines
Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage
Articles by:
DMD Warrior
Press Releases
Capricor Therapeutics Announces Positive 4-Year Data of Deramiocel (CAP-1002) in Duchenne Muscular Dystrophy
Editorials
After Second Patient Death, Duchenne Muscular Dystrophy Communities Want Answers About Elevidys Gene Therapy
Press Releases
Capricor Therapeutics Announces BMD Orphan Drug Designation and DMD Program Regulatory Development for Deramiocel (CAP-1002)
Press Releases
Sarepta Reported Elevidys Gene Therapy for Duchenne Muscular Dystrophy will not be used in non-ambulatory patients
ELEVIDYS
Approved Therapies
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Press Releases
New Positive Functional Data From The RGX-202 Affinity Duchenne® Trial Phase 1/2 Reported By Regenxbio
Regenxbio RGX-202
Press Releases
PepGen Announces It Will Halt Clinical Trials of Exon 51 Skipping Study
Press Releases
Entrada Therapeutics Receives EU Authorization to Start Exon 45 Skipping Clinical Trial in Duchenne Muscular Dystrophy
1
...
27
28
29
...
46
Page 28 of 46
Latest Posts
Research
DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD
Care Guidelines
What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?
Care Guidelines
Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage
Research
Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy
Don't Miss
DMD
Investigational New Drug (IND) Clearance for Duchenne Muscular Dystrophy: Process, Trials & Future Therapies
Editorials
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
Care Guidelines
Hydrotherapy in Duchenne Muscular Dystrophy (DMD): Benefits, Exercises, and Clinical Evidence
Care Guidelines
Newly Diagnosed Patients with Duchenne Muscular Dystrophy: A Complete Family Guide
Press Releases
New Hope for Duchenne: Ryoncil Clinical Trial Begins
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language
Close and do not switch language
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language